Press Releases

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices,putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed...

The implementation of the “Healthy China 2030” Planning Outline has ushered in rapid development of China’s big health industry, with the industry scale expected to reach RMB8.78 trillion in 2019 and RMB14.09 trillion in 2023, calculated as per the...

CPhI Worldwide announces the finalists for the CPhI Pharma Awards. The shortlist spans 13 different categories across the full spectrum of the pharmaceutical supply chain, including Formulation, Packaging and Lifetime Achievement Awards. The winners of the 16th CPhI Pharma Awards...

GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta T-cells to develop transformational immunotherapies, announced the formation of a spin-out company: Adaptate Biotherapeutics. While GammaDelta Therapeutics’ primary goal is to develop γδ T-cell based cell...

Replimune Group Inc. , a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, announced that the first patient has been enrolled in its registration-directed, randomized, controlled Phase 2 clinical trial of RP1 in combination with Regeneron...

Alexion Pharmaceuticals, Inc. and Stealth BioTherapeutics Corp announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being evaluated in a Phase 3 study in people with primary mitochondrial myopathy (PMM) - a genetic...

Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. FDA has approved rivaroxaban (Xarelto) for the prevention of venous thromboembolism (VTE), or blood clots, in acutely ill medical patients at risk for thromboembolic...